Stay updated with breaking news from Deborah Telman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- At a time when suspicion, intolerance, and virulent rhetoric tear at the fabric of our society, The Black Women's Agenda, Inc. (BWA) is...
#2023USCHA was a Love Letter to Black Women—and a joyous family reunion for the HIV community. [VIDEOS]
CityWatch is published 24/7 with special e-news blasts on Monday and Thursday evening, with Extras as appropriate around special events such as elections or imp
/cloudfront-ap-southeast-2.images.arcpublishing.com/nzme/XAHVFL5KJNEWNGXIENYNV4ANW4.jpg)
New York Times: Company devised plan to delay new drug’s release to maximise profits.
Today, a generation of expensive Gilead drugs containing the new iteration of tenofovir account for half of the market for HIV treatment and prevention, according to IQVIA, an industry data provider. One widely used product, Descovy, has a sticker price of $26,000 annually. Generic versions of its predecessor, Truvada, whose patents have expired, now cost less than $400 a year.